Abstract
Vascular endothelial growth factor (VEGF), plays a key role in angiogenesis. Many endogenous factors can affect angiogenesis in endothelial cells. VEGF is known to be a strong migration, sprouting, survival, and proliferation factor for endothelial cells during angiogenesis in endothelial cells. Searching for novel genes, involved in VEGF signaling during angiogenesis, we carried out differential display polymerase chain reaction on RNA from VEGF-stimulated human umbilical vein endothelial cells (HUVECs). In this study, follistatin (FS) differentially expressed in VEGF-treated HUVECs, compared with controls. Addition of VEGF (10 ng/mL) produced an approximately 11.8-fold increase of FS mRNA. FS or VEGF produced approximately 1.8- or 2.9-fold increases, respectively, in matrix metalloproteinase-2 (MMP-2) secretion for 12 h, compared to the addition of a control buffer. We suggest that VEGF may affect the angiogenic effect of HUVECs, through a combination of the direct effects of VEGF itself, and the indirect effects mediated via induction of FSin vitro.
Similar content being viewed by others
References
Gerber, H. P., A. McMurtrey, J. Kowalski, M. Yan, B. A. Keyt, V. Dixit, and N. Ferrara (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway.J. Biol. Chem. 273: 30336–30343.
Ferrara, N. (1996) Vascular endothelial growth factor.Eur. J. Cancer 32: 2413–2422.
Carmeliet, P. (2003) Angiogenesis in health and disease.Nat. Med. 9: 653–660.
de Vries, C., J. A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L. T. Williams (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.Science 255: 989–991.
Millauer, B., S. Wizigmann-Voos, H. Schnurch, R. Martinez, N. P. H. Moller, W. Risau, and A. Ulrich (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.Cell 72: 835–846.
Hockel, M., K. Schlenger, S. Doctrow, T. Kissel, and P. Vaupel (1993) Therapeutic angiogenesis.Arch. Surg. 128: 423–429.
Isner, J. M. and D. W. Losordo (2003) Therapeutic angiogenesis for heart failure.Nat. Med. 5: 491–492.
Brusselmans, K., F. Bono, P. Maxwell, Y. Dor, M. Dewerchin, D. Collen, J. M. Herbert, and P. Carmeliet (2001) Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia.J. Biol. Chem. 276: 39192–39196.
Neufeld, G., T. Cohen, S. Gengrinovitch, and Z. Poltorak (1999) Vascular endothelial growth factor (VEGF) and its receptors.FASEB J. 13: 9–22.
Robertson, D. M., R. Klein, F. L. de Vos, R. I. McLachlan, R. E. Wettenhall, M. T. Hearn, H. G. Burger, and D. M. de Kretser (1987) The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin.Biochem. Biophys. Res. Commu. 149: 744–749.
Ueno, N., N. Ling, S. Y. Ying, F. Esch, S. Shimasaki, and R. Guillemin (1987) Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone.Proc. Natl. Acad. Sci. USA 84: 8282–8286.
Kawakami, S., Y. Fujii, and S. J. Winters (2001) Follistatin production by skin fibroblasts and its regulation by dexamethasone.Mol. Cell. Endocrinol. 172: 157–167.
DePaolo, L. V. (1997) Inhibins, activins, and follistatins: the saga continues.Exp. Biol. Med. 214: 328–339.
Risau, W. (1997) Mechanisms of angiogenesis.Nature 386: 671–674.
Folkman, J. and Y. Shing (1992) Angiogenesis.J. Biol. Chem. 267: 10931–10934.
Brooks, P. C., S. Silletti, T. L. von Schalscha, M. Friedlander, and D. A. Cheresh (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.Cell 92: 391–400.
Liang, P. and A. B. Pardee (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.Science 257: 967–971.
Kim, I., S. O. Moon, K. N. Koh, H. Kim, C. S. Uhm, H. J. Kwak, N. G. Kim, and G.Y. Koh (1999) Molecular cloning, expression, and characterization of angiopoietin-related protein induces endothelial cell sprouting.J. Biol. Chem. 274: 26523–26528.
Kleinen, D. E., I. M. K. Margulis, W. G. Stetler-Stevenson (1998) Cell and tissue culture: Laboratory procedures. pp. 5A7.1–5A7.8. In: A. Doyle, J. B. Griffiths, and D. G. Newell (eds.), Wiley, Sussex, UK.
Badruddoja, M. A., H. G. Krouwer, S. D. Rand, K.J. Rebro, A. P. Pathak, and K. M. Schmainda (2003) Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps.Neuro-oncol. 5: 235–243.
Clerch, L. B., A. S. Baras, G. D. Massaro, E. P. Hoffman, and D. Massaro (2004) DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation.Am. J. Physiol. Lung Cell. Mol. Physiol. 286: 411–419.
Kaiser, U. B., B. L. Lee, R. S. Carroll, G. Unabia, W. W. Chin, and G. V. Childs (1992) Follistatin gene expression in the pituitary: localization in gonadotropes and folliculostellate cells in diestrous rats.Endocrinology 130: 3048–3056.
Kozian, D. H., M. Ziche, and H. G. Augustin (1997) The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis.Lab. Invest. 76: 267–276.
Pepper, J. S., R. Montesano, S. J. Mandriota, L. Orci, and J. D. Vassalli (1996) Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis.Enzyme Protein 49: 138–162.
Hiraoka, N., E. Allen, I. J. Apel, M. R. Gyetko, and S. J. Weiss (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.Cell 95: 365–377.
Brown, M. D. and O. Hudlicka (2003) Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases.Angiogenesis 6: 1–14.
Kliche, S. and J. Waltenberger (2001) VEGF receptor signaling and endothelial function.IUBMB Life 52: 61–66.
Wang, H. and J. A. Keiser (1998) Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.Circ. Res. 83: 832–840.
Itaya, H., T. Imaizumi, H. Yoshida, M. Koyama, S. Suzuki, and K. Satoh (2001) Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide.Thromb. Haemost. 85: 171–176.
Haas, T. L., M. Milkiewicz, S. J. Davis, A. L. Zhou, S. Egginton, M. D. Brown, J. A. Madri, and O. Hudlicka (2000) Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle.Am. J. Physiol. Heart Circ. Physiol. 279: 1540–1547.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oh, I.S., Kim, H.G. Vascular endothelial growth factor upregulates follistatin in human umbilical vein endothelial cells. Biotechnol. Bioprocess Eng. 9, 201–206 (2004). https://doi.org/10.1007/BF02942293
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02942293